Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 101751-101800 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04495985
CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer
N/A
Active, not recruiting
39 participants
Started: Jul 14, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04029337
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
NA
Recruiting
30 participants
Started: Jul 14, 2020 · Completed: Dec 31, 2030
1 condition
1 sponsor
10 locations
NCT04468659
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
PHASE3
Active, not recruiting
1,400 participants
Started: Jul 14, 2020 · Completed: Jan 16, 2031
2 conditions
4 sponsors
109 locations
NCT04114669
Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)
NA
Active, not recruiting
401 participants
Started: Jul 14, 2020 · Completed: Oct 30, 2025
1 condition
2 sponsors
1 location
NCT04481763
A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast
PHASE1/PHASE2
Recruiting
20 participants
Started: Jul 14, 2020 · Completed: Oct 1, 2026
1 condition
1 sponsor
1 location
NCT05072691
Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis
N/A
Recruiting
100 participants
Started: Jul 14, 2020 · Completed: Jan 1, 2030
1 condition
1 sponsor
1 location
NCT04167358
Linerixibat Long-term Safety, and Tolerability Study
PHASE3
Active, not recruiting
245 participants
Started: Jul 14, 2020 · Completed: Aug 31, 2027
1 condition
1 sponsor
95 locations
NCT04015700
Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
PHASE1
Active, not recruiting
9 participants
Started: Jul 14, 2020 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT04316364
A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC
PHASE3
Recruiting
537 participants
Started: Jul 14, 2020 · Completed: Dec 15, 2026
1 condition
1 sponsor
7 locations
NCT04021355
Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans
NA
Active, not recruiting
55 participants
Started: Jul 14, 2020 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT04485013
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
PHASE1
Recruiting
240 participants
Started: Jul 14, 2020 · Completed: Jun 1, 2027
1 condition
1 sponsor
39 locations
NCT05863676
Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy
N/A
Active, not recruiting
20 participants
Started: Jul 14, 2020 · Completed: Jul 31, 2030
2 conditions
1 sponsor
1 location
NCT02616484
Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:
PHASE3
Active, not recruiting
34 participants
Started: Jul 14, 2020 · Completed: Aug 27, 2025
1 condition
2 sponsors
10 locations
NCT04230109
Sacituzumab Govitecan In TNBC
PHASE2
Recruiting
260 participants
Started: Jul 14, 2020 · Completed: Oct 31, 2029
5 conditions
2 sponsors
5 locations
NCT04731220
A Questionnaire Survey for Biliary Tract Cancers
N/A
Enrolling by invitation
12,000 participants
Started: Jul 14, 2020 · Completed: Dec 31, 2025
1 condition
4 sponsors
1 location
NCT03992430
A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)
PHASE3
Active, not recruiting
160 participants
Started: Jul 13, 2020 · Completed: Oct 31, 2026
1 condition
1 sponsor
59 locations
NCT04497779
Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma
N/A
Active, not recruiting
95 participants
Started: Jul 13, 2020 · Completed: Nov 7, 2025
2 conditions
3 sponsors
1 location
NCT04483778
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
PHASE1
Active, not recruiting
68 participants
Started: Jul 13, 2020 · Completed: Dec 31, 2040
17 conditions
1 sponsor
1 location
NCT04399200
Apnea, Stroke and Incident Cardiovascular Events
N/A
Recruiting
1,620 participants
Started: Jul 13, 2020 · Completed: Jun 1, 2035
6 conditions
1 sponsor
1 location
NCT04310007
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
117 participants
Started: Jul 13, 2020 · Completed: Dec 31, 2026
3 conditions
1 sponsor
616 locations
NCT04423029
A Study of DF6002 Alone and in Combination With Nivolumab
PHASE1
Recruiting
438 participants
Started: Jul 13, 2020 · Completed: Nov 30, 2027
1 condition
1 sponsor
33 locations
NCT04520269
A Single Arm, Phase Ib/II Trial of Single Agent Pacritinib in Patients With 1q21.3 Amplified Solid Tumors Enriching for Interleukin-1 Receptor-associated Kinase 1 Pathway Activation (PAIR)
PHASE1/PHASE2
Active, not recruiting
74 participants
Started: Jul 13, 2020 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT04150640
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
PHASE2
Recruiting
52 participants
Started: Jul 13, 2020 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT04445844
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study
PHASE2
Active, not recruiting
25 participants
Started: Jul 13, 2020 · Completed: Jun 30, 2025
5 conditions
4 sponsors
2 locations
NCT04493853
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency
PHASE3
Active, not recruiting
1,012 participants
Started: Jul 13, 2020 · Completed: Mar 29, 2027
1 condition
1 sponsor
323 locations
NCT04425018
MARGetuximab Or Trastuzumab (MARGOT)
PHASE2
Active, not recruiting
174 participants
Started: Jul 13, 2020 · Completed: Jul 1, 2027
4 conditions
3 sponsors
14 locations
NCT04551378
The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
N/A
Recruiting
600 participants
Started: Jul 13, 2020 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT06315933
Anesthesia Neurodevelopmental Impact in Congenital Scoliosis Children
N/A
Recruiting
100 participants
Started: Jul 13, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04235777
Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
PHASE1
Recruiting
100 participants
Started: Jul 13, 2020 · Completed: Dec 1, 2027
5 conditions
1 sponsor
1 location
NCT04438889
Austrian Myeloid Registry
N/A
Recruiting
3,000 participants
Started: Jul 13, 2020 · Completed: Apr 30, 2030
1 condition
1 sponsor
16 locations
NCT06706700
Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas
N/A
Recruiting
586 participants
Started: Jul 13, 2020 · Completed: Mar 31, 2025
2 conditions
1 sponsor
1 location
NCT04307576
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
PHASE3
Recruiting
6,430 participants
Started: Jul 13, 2020 · Completed: Jun 30, 2033
1 condition
23 sponsors
130 locations
NCT03832855
Assessing the Immunogenicity of pING-hHER3FL
PHASE1
Active, not recruiting
10 participants
Started: Jul 13, 2020 · Completed: Mar 31, 2030
1 condition
1 sponsor
1 location
NCT04303117
NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
PHASE1/PHASE2
Recruiting
80 participants
Started: Jul 13, 2020 · Completed: Dec 1, 2028
1 condition
1 sponsor
1 location
NCT04871399
Complete Mesocolic Excision in Comparison With Conventional Surgery for the Right Colon Cancer
NA
Recruiting
416 participants
Started: Jul 13, 2020 · Completed: Jan 1, 2027
1 condition
13 sponsors
14 locations
NCT04551170
Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old
PHASE2
Recruiting
34 participants
Started: Jul 13, 2020 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT06058182
RNA as Prognostic Biomarkers in Patients With Acute Coronary Syndrome
N/A
Recruiting
70 participants
Started: Jul 13, 2020 · Completed: Jan 30, 2027
1 condition
1 sponsor
1 location
NCT04848090
Genome Sequencing in the Intensive Care Unit Population
NA
Enrolling by invitation
400 participants
Started: Jul 13, 2020 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT04450225
The Psychometric Properties of the Italian Version of the Reintegration to Normal Living Index in Complex Patients
N/A
Recruiting
158 participants
Started: Jul 13, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04794686
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
N/A
Recruiting
100 participants
Started: Jul 12, 2020 · Completed: Jul 12, 2030
1 condition
1 sponsor
1 location
NCT04391595
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
EARLY_PHASE1
Active, not recruiting
50 participants
Started: Jul 11, 2020 · Completed: Feb 13, 2028
3 conditions
4 sponsors
3 locations
NCT04477863
Follow-up With Preimplantation Genetic Testing Patients
N/A
Recruiting
10,000 participants
Started: Jul 11, 2020 · Completed: Dec 31, 2050
3 conditions
1 sponsor
1 location
NCT04428905
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer
PHASE3
Active, not recruiting
403 participants
Started: Jul 11, 2020 · Completed: Sep 30, 2026
22 conditions
2 sponsors
1 location
NCT05006131
Pancreatic Cancer Screening for At-risk Individuals
N/A
Recruiting
1,395 participants
Started: Jul 10, 2020 · Completed: Dec 31, 2032
1 condition
7 sponsors
1 location
NCT04560673
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
PHASE2
Recruiting
380 participants
Started: Jul 10, 2020 · Completed: Dec 31, 2025
3 conditions
2 sponsors
2 locations
NCT04430894
KRDI in Transplant-Eligible MM
PHASE2
Active, not recruiting
50 participants
Started: Jul 10, 2020 · Completed: Mar 30, 2026
1 condition
3 sponsors
3 locations
NCT06163846
Image Mining and ctDNA to Improve Risk Stratification and Outcome Prediction in NSCLC Applying Artificial Intelligence.
N/A
Recruiting
415 participants
Started: Jul 10, 2020 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT04207944
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
PHASE2
Active, not recruiting
100 participants
Started: Jul 10, 2020 · Completed: Oct 31, 2026
2 conditions
5 sponsors
4 locations
NCT05982119
Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
NA
Recruiting
300 participants
Started: Jul 10, 2020 · Completed: Mar 31, 2026
6 conditions
2 sponsors
8 locations
NCT04321408
OP2C : Prialt® Observatory in Clinical Practice
N/A
Recruiting
300 participants
Started: Jul 10, 2020 · Completed: Sep 30, 2027
1 condition
2 sponsors
17 locations
Previous
1
More pages
2033
2034
2035
2036
2037
2038
2039
More pages
2369
Next